RECURSION PHARMACEUTICALS IN

Ticker: RXRX CUSIP: 75629V104 Class: Common Stock

Bellevue Group AG's Holding History (CIK: 0001674546)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 4,921 Value ($000) $20 Avg Close $4.95 Range $3.81 - $7.18

Q3 2025

Shares 5,514 Value ($000) $27 Avg Close $5.25 Range $4.45 - $7.15

Q2 2025

Shares 5,514 Value ($000) $28 Avg Close $4.91 Range $3.79 - $6.11

Q1 2025

Shares 195,052 Value ($000) $1,032 Avg Close $7.29 Range $5.19 - $12.36

Q4 2024

Shares 377,806 Value ($000) $2,554 Avg Close $6.72 Range $5.60 - $9.55

Q3 2024

Shares 392,881 Value ($000) $2,589 Avg Close $7.17 Range $5.88 - $8.73

Q2 2024

Shares 425,810 Value ($000) $3,194 Avg Close $8.72 Range $6.75 - $10.66

Q1 2024

Shares 425,249 Value ($000) $4,240 Avg Close $11.14 Range $8.68 - $15.74

Q4 2023

Shares 174,557 Value ($000) $1,721 Avg Close $7.13 Range $4.97 - $11.17

Q3 2023

Shares 174,085 Value ($000) $1,332 Avg Close $9.98 Range $6.44 - $16.75

Q2 2021

Shares 20,000 Value ($000) $730 Avg Close $29.60 Range $19.68 - $38.39

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	4,921	$20	$4.95	$3.81 - $7.18
Q3 2025	5,514	$27	$5.25	$4.45 - $7.15
Q2 2025	5,514	$28	$4.91	$3.79 - $6.11
Q1 2025	195,052	$1,032	$7.29	$5.19 - $12.36
Q4 2024	377,806	$2,554	$6.72	$5.60 - $9.55
Q3 2024	392,881	$2,589	$7.17	$5.88 - $8.73
Q2 2024	425,810	$3,194	$8.72	$6.75 - $10.66
Q1 2024	425,249	$4,240	$11.14	$8.68 - $15.74
Q4 2023	174,557	$1,721	$7.13	$4.97 - $11.17
Q3 2023	174,085	$1,332	$9.98	$6.44 - $16.75
Q2 2021	20,000	$730	$29.60	$19.68 - $38.39